These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25064019)

  • 1. Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use.
    Dougherty DM; Hill-Kapturczak N; Liang Y; Karns TE; Cates SE; Lake SL; Mullen J; Roache JD
    Drug Alcohol Depend; 2014 Sep; 142():301-6. PubMed ID: 25064019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking.
    Dougherty DM; Karns TE; Mullen J; Liang Y; Lake SL; Roache JD; Hill-Kapturczak N
    Drug Alcohol Depend; 2015 Mar; 148():77-84. PubMed ID: 25582388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using contingency management procedures to reduce at-risk drinking in heavy drinkers.
    Dougherty DM; Lake SL; Hill-Kapturczak N; Liang Y; Karns TE; Mullen J; Roache JD
    Alcohol Clin Exp Res; 2015 Apr; 39(4):743-51. PubMed ID: 25833033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor.
    Barnett NP; Tidey J; Murphy JG; Swift R; Colby SM
    Drug Alcohol Depend; 2011 Nov; 118(2-3):391-9. PubMed ID: 21665385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor.
    Barnett NP; Celio MA; Tidey JW; Murphy JG; Colby SM; Swift RM
    Addiction; 2017 Jun; 112(6):1025-1035. PubMed ID: 28107772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitators and barriers to a contingency management alcohol intervention involving a transdermal alcohol sensor.
    Villalba K; Cook C; Dévieux JG; Ibanez GE; Oghogho E; Neira C; Cook RL
    Heliyon; 2020 Mar; 6(3):e03612. PubMed ID: 32258468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences with SCRAMx alcohol monitoring technology in 100 alcohol treatment outpatients.
    Alessi SM; Barnett NP; Petry NM
    Drug Alcohol Depend; 2017 Sep; 178():417-424. PubMed ID: 28709081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring alcohol use in heavy drinking soup kitchen attendees.
    Rash CJ; Petry NM; Alessi SM; Barnett NP
    Alcohol; 2019 Dec; 81():139-147. PubMed ID: 30308286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic and clinical factors associated with transdermal alcohol concentration from the SCRAM biosensor among persons living with and without HIV.
    Richards VL; Liu Y; Orr J; Leeman RF; Barnett NP; Bryant K; Cook RL; Wang Y
    Alcohol Clin Exp Res; 2021 Sep; 45(9):1804-1811. PubMed ID: 34342009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal alcohol monitoring combined with contingency management for driving while impaired offenders: A pilot randomized controlled study.
    Averill F; Brown TG; Robertson RD; Tchomgang A; Berbiche D; Nadeau L; Ouimet MC
    Traffic Inj Prev; 2018 Jul; 19(5):455-461. PubMed ID: 29543499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness.
    McDonell MG; Leickly E; McPherson S; Skalisky J; Srebnik D; Angelo F; Vilardaga R; Nepom JR; Roll JM; Ries RK
    Am J Psychiatry; 2017 Apr; 174(4):370-377. PubMed ID: 28135843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced alcohol use increases drink-refusal self-efficacy: Evidence from a contingency management study for DWI arrestees.
    Wood EE; Liang Y; Moon TJ; Wasserman AM; Lamb RJ; Roache JD; Hill-Kapturczak N; Dougherty DM
    Drug Alcohol Depend; 2023 Jan; 242():109706. PubMed ID: 36493503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness.
    McDonell MG; Leickly E; McPherson S; Skalisky J; Hirchak K; Oluwoye O; Srebnik D; Roll JM; Ries RK
    Am J Addict; 2017 Oct; 26(7):673-675. PubMed ID: 28833832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of detection of alcohol use episodes using a transdermal alcohol sensor.
    Barnett NP; Meade EB; Glynn TR
    Exp Clin Psychopharmacol; 2014 Feb; 22(1):86-96. PubMed ID: 24490713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An experimental trial exploring the impact of continuous transdermal alcohol monitoring upon alcohol consumption in a cohort of male students.
    Neville FG; Williams DJ; Goodall CA; Murer JS; Donnelly PD
    PLoS One; 2013; 8(6):e67386. PubMed ID: 23825656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contingency management in the treatment of adolescent alcohol drinking problems.
    Brigham SL; Rekers GA; Rosen AC; Swihart JJ; Pfrimmer G; Ferguson LN
    J Psychol; 1981 Sep; 109(1st Half):73-85. PubMed ID: 7288676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterising patterns of alcohol use among heavy drinkers: A cluster analysis utilising alcohol biosensor data.
    Gunn RL; Steingrimsson JA; Merrill JE; Souza T; Barnett N
    Drug Alcohol Rev; 2021 Nov; 40(7):1155-1164. PubMed ID: 33987927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the quantity and time course of alcohol consumption from transdermal alcohol sensor data: A combined laboratory-ambulatory study.
    Fairbairn CE; Rosen IG; Luczak SE; Venerable WJ
    Alcohol; 2019 Dec; 81():111-116. PubMed ID: 30179707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote Alcohol Monitoring to Facilitate Incentive-Based Treatment for Alcohol Use Disorder: A Randomized Trial.
    Koffarnus MN; Bickel WK; Kablinger AS
    Alcohol Clin Exp Res; 2018 Dec; 42(12):2423-2431. PubMed ID: 30335205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Dynamics of Transdermal Alcohol Concentration Measured via New-Generation Wrist-Worn Biosensor.
    Fairbairn CE; Kang D
    Alcohol Clin Exp Res; 2019 Oct; 43(10):2060-2069. PubMed ID: 31469451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.